ArticleJournal of translational medicine2023

Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.

Tao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.